The American Society for Preventive Cardiology (ASPC) has announced the development of a 2-year fellowship program that will support the creation of cardiometabolic training programs nationwide and increase the number of expert clinicians equipped to effectively manage patients with cardiometabolic risk factors. The first cardiometabolic fellow-in-training is slated to begin as early as July 2024.
ASPC President, Martha Gulati, MD states "Metabolic diseases are noted to have a strong association with increased risk of many chronic diseases including atherosclerotic cardiovascular disease, stroke, heart failure, chronic kidney disease, non-alcoholic fatty liver disease, sleep apnea, atrial fibrillation, dementia, and cancer. As the epidemic of the metabolic diseases continues to worsen, comprehensive management of cardiometabolic diseases is crucial to prevent downstream diseases and adverse effects."
Historically, the care of cardiometabolic diseases has been fragmented between primary care physicians and specialists such as endocrinologists, cardiologists, and less often hepatologists and nephrologists. This approach has been characterized by sparse interaction among specialists and lack of ownership of the field by any specialty or type of physician. As a result, the cardiometabolic patient is left without a "home", instead being shuffled between primary and specialty clinics.
The ASPC's cardiometabolic training program is designed for institutions and centers with established Cardiometabolic Clinics and ready access to experts of multiple specialties for the overall care of cardiometabolic patients.
Now available on the ASPC's website www.aspconline.org is an overview of this program's requirements, eligibility for institutions to receive the grant, and the institutional grant application. The goal of each grant is to support institutions in developing the new fellowship program, as well as to provide salary assistance, travel, and publication costs for a single two-year fellow.
Comments powered by CComment